Rapid Antigen Tests
RightSign COVID-19 RAT Rapid Antigen Test (2)
RightSign COVID-19 RAT Rapid Antigen Test
The RightSign COVID-19 Rapid Antigen Test Cassette (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of COVID-19 antigen in a Nasal Swab. The identification is based on the monoclonal antibodies specific for the Nucleocapsid (N) protein of SARS-CoV-2. It is intended to aid in the rapid differential diagnosis of current COVID-19 infections.
The results are used to identify the SARS-CoV-2 antigen test within the first 7 days of symptom onset when viral shedding/viral load is at its highest. This antigen is generally found in upper respiratory tract samples during the acute phase of infection. Positive results suggest the presence of viral antigens, but an individual medical history and other diagnostic information are necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The pathogen identified may not be the exact cause of the disease. Individuals who test positive should confirm the results with a laboratory PCR test, self-isolate and notify their healthcare provider.
Painless
> Avoid the discomfort of nasopharyngeal swab sampling
Convenient
> Easy to operate, interpret result at 10 minutes
Accurate
> Excellent performance compared to molecular methods
Each test includes
> Test cassette
> Prefilled buffer
> Dropper tip
> Sterile nasal swab
> Package insert
> Quick reference guide
> Disposal bag
RightSign COVID-19 RAT Rapid Antigen Test (5)
RightSign COVID-19 RAT Rapid Antigen Test
The RightSign COVID-19 Rapid Antigen Test Cassette (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of COVID-19 antigen in a Nasal Swab. The identification is based on the monoclonal antibodies specific for the Nucleocapsid (N) protein of SARS-CoV-2. It is intended to aid in the rapid differential diagnosis of current COVID-19 infections.
The results are used to identify the SARS-CoV-2 antigen test within the first 7 days of symptom onset when viral shedding/viral load is at its highest. This antigen is generally found in upper respiratory tract samples during the acute phase of infection. Positive results suggest the presence of viral antigens, but an individual medical history and other diagnostic information are necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The pathogen identified may not be the exact cause of the disease. Individuals who test positive should confirm the results with a laboratory PCR test, self-isolate and notify their healthcare provider.
Painless
> Avoid the discomfort of nasopharyngeal swab sampling
Convenient
> Easy to operate, interpret result at 10 minutes
Accurate
> Excellent performance compared to molecular methods
Each test includes
> Test cassette
> Prefilled buffer
> Dropper tip
> Sterile nasal swab
> Package insert
> Quick reference guide
> Disposal bag